FoundersArvind Sontha FounderArvind Sontha FounderSimilar JobsVoicepanelFounding Account ExecutivePureFounding GTM Leader (Sales)Brainbase LabsFounding GTMCraniometrixSales Director (Series A Healthtech)Saphira AIFounding Account Executive - Enterprise Safety & Compliance (Hardware + AI)TractianSales Account ExecutiveNotabeneSales Director, Americas (Institutional)EmbraceBusiness Development LeadTerminalFounding Account Executive [In-Person, Toronto]KomboBusiness Development LeadAptenFounding SDRLandeedBusiness Development And Enterprise Sales (BDES)ScoutSales DevelopmentExaAccount ExecutiveZaymoMidmarket Customer Success ManagerEnerjazzSales Manager – Field & Telecalling Team LeadNewsCatcherSales Development Representative (SDR)Surface LabsSales Development RepresentativeMacadamiaFounding GTM Lead JuiceboxCustomer Success ManagerFooterY CombinatorMake something people want.ProgramsYC ProgramStartup SchoolWork at a StartupCo-Founder MatchingResourcesStartup DirectoryStartup LibraryInvestorsDemo DaySafeHacker NewsLaunch YCYC DealsCompanyYC BlogContactPressPeopleCareersPrivacy PolicyNotice at CollectionSecurityTerms of UseTwitterTwitterFacebookFacebookInstagramInstagramLinkedInLinkedInYoutubeYouTube© 2026 Y Combinator
Глеб Макаревичсотрудник Центра Индоокеанского региона ИМЭМО РАН，这一点在服务器推荐中也有详细论述
ATM reads the card number (called Primary Account Number or PAN) off of the，推荐阅读51吃瓜获取更多信息
Sign up now! Sign up now! Sign up now? Sign up now!
有趣的是，Infigratinib最初于2021年获批用于胆管癌，后因适应症开发策略调整而主动撤回。如今，其有望在ACH赛道迎来“第二春”。基于其疗效和口服便利性，BridgeBio在今年的JPM大会上预测，该药Infigratinib将占据ACH治疗市场50%以上的份额。